Loan & DebtJun 25, 2026, 06:07 AM
Mesoblast Draws $50M from 5-Year Facility, Refinances Debt
AI Summary
Mesoblast Limited announced it drew down US$50 million from a new five-year, non-dilutive facility provided by director Dr. Gregory George. This funding will optimize the company's capital structure by retiring higher-cost, short-term debt from NovaQuest Capital Management LLC. The new facility features a fixed interest rate of 8.00% per annum, a significant reduction from previous facilities, and is secured solely by the Temcell royalty. The company reported US$122 million in cash as of March 30, 2026, and states it is well-funded for its commercial operations and growth pipeline.
Key Highlights
- Mesoblast drew US$50 million from a new five-year, non-dilutive facility.
- The facility was provided by existing shareholder and director Dr. Gregory George.
- Funds will be used to retire higher-cost NovaQuest Capital Management LLC debt.
- The new facility has a fixed interest rate of 8.00% per annum.
- It is secured solely with the Temcell royalty and has no early repayment or exit fees.
- Mesoblast reported US$122 million cash at March 30, 2026.
Price Impact
More from MESO